NCT04480788 2021-01-06
CD7-CART in the Treatment of r / r CD7 Positive Hemolymph System Malignancies on Increasing Dose and Open Label Study
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Phase 1 Unknown
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Immune Cell, Inc.